The U.S. Food and Drug Administration (FDA) has established fiscal year 2015 drug facility user fees that have increased 12-15 percent over current rates. The new fees will take effect October 1, 2014. Facilities in India, which is the largest source of medicines to the United States, will pay more than domestic facilities. According to a news source, India currently has 150 FDA-approved plants. A foreign finished dosage form (FDF) facility will pay $262,717 compared to a domestic FDF, which will pay $247,717. A foreign active pharmaceutical ingredient facility (API) will pay $56,926, and a domestic API facility will pay $41,926. Some user-fee rates have fallen; for example, the new fee for drug master files is $26,720, down 15 percent from the previous year, and the rates for abbreviated new drug applications have been lowered some 8 percent to $58,730. See Federal Register, August 1, 2014;, August 3, 2014.